University of Minnesota announces clinical trial for opioid vaccine

Drug Discovery & Development | September 7, 2021

The University of Minnesota Medical School has developed a therapeutic vaccine for opioid use disorder that is the subject of a new Phase 1 randomized placebo-controlled clinical trial. Marco Pravetoni, PhD, is leading the drug discovery research and will join the UW Medicine Garvey Institute for Brain Health Solutions in 2022.

Beyond dopamine: New reward circuitry discovered

UW Medicine newsroom | September 1, 2021

In a paper published in Nature Neuroscience, researchers pushed the science forward on our reward pathways. Co-lead author Raajaram Gowrishankar, PhD, is a postdoctoral scholar in the Bruchas Lab and the Center for the Neurobiology of Addiction, Pain and Emotion (NAPE).

King County fentanyl overdoses spike to record high

UW Medicine newsroom | August 31, 2021

UW Medicine addiction researcher Caleb Banta-Green says drug manufacturers and dealers are purposefully making and selling counterfeit pills that are actually illegally made fentanyl. The synthetic opioid is 50 to 100 times more potent than morphine.